Quest Diagnostics earnings bolstered by March rebound, sending stock up 3% - MarketWatch
1. DGX reported a 3% stock rise post better-than-expected earnings. 2. Q1 net income increased to $220 million from $194 million year-over-year. 3. Adjusted EPS rose 8.3% to $2.21, surpassing consensus estimates. 4. Revenue grew 12.1% to $2.652 billion, exceeding expectations. 5. Company reaffirmed revenue guidance of $10.7-$10.85 billion for 2025.